Eben Lichtman

Eben Lichtman, MD is an Assistant Professor of Medicine at the University of North Carolina at Chapel Hill School of Medicine, specializing in the Division of Hematology. He is also an associate member of the Lineberger Comprehensive Cancer Center, where he focuses on plasma cell disorders including multiple myeloma, smoldering multiple myeloma, AL amyloidosis, and rare conditions such as POEMS syndrome.

• Undergraduate: Oberlin College and Conservatory
• Medical School: University of Massachusetts Medical School
• Residency: Boston University Medical Center
• Fellowship: University of North Carolina at Chapel Hill

Dr. Lichtman's research primarily centers on developing and conducting clinical trials for novel therapeutic strategies in multiple myeloma, with special emphasis on older and frail myeloma patients. His work includes investigating CAR T cell therapies for hematologic malignancies. His clinical expertise includes the diagnosis and management of high-risk multiple myeloma and AL amyloidosis.

His recent publications demonstrate a strong focus on multiple myeloma research, with particular attention to geriatric assessment in myeloma patients, cognitive function in plasma cell disorders, and clinical trial accessibility across different socioeconomic groups. His work spans from basic CAR T cell therapy mechanisms to real-world treatment patterns using SEER Medicare data.

Dr. Lichtman collaborates extensively with colleagues across UNC's Lineberger Comprehensive Cancer Center, particularly with researchers focusing on geriatric oncology, quality of life metrics, and health disparities in cancer treatment.